Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus: A prospective, double-blind, randomized study

Digestive Diseases and Sciences

Volumn 41, Issue 6, 1996, Pages 1241-1247

  Villa, Erica ^a   Trande, Paolo ^a   Grottola, Antonella ^a   Buttafoco, Paola ^a   Rebecchi, Anna Maria ^a   Stroffolini, Tommaso ^a   Callea, Francesco ^a   Merighi, Annalisa ^a   Camellini, Lorenzo ^a   Zoboli, Patrizia ^a   Cosenza, Rossella ^a   Miglioli, Lucia ^a   Loria, Paola ^a   Iori, Rossella ^a   Carulli, Nicola ^a   Manenti, Federico ^a  

^a Department of Gastroenterology ^*

Author keywords

Chronic hepatitis C; HCV genotype; Interferon ; Interferon ; Randomized controlled trial

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; CHRONIC ACTIVE HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS, CHRONIC; HUMANS; INTERFERON TYPE I, RECOMBINANT; INTERFERON-ALPHA; INTERFERON-BETA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, VIRAL;

EID: 8944234351     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02088244     Document Type: Article

References (27)

1. Tinè F, Magrin S, Craxì A, Pagliaro L: Interferon tor nonA, nonB chronic hepatitis. A meta-analysis of randomized clinical trials. J Hepatol 13:192-199, 1991
2. Liddle C: Interferon treatment of hepatitis C - Is it a virological cure? J Gastroenterol Hepatol 8:209-211, 1993
3. Omata M, Yokosuka O, Takano S, Kato N, Hosoda K, Imazeki F, Tada M, Ito Y, Ohio M: Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 338:914-915, 1991
4. Nagashima H, Arima T, Suzuki H: Treatment of chronic nonA, nonB hepatitis with human interferon-β. J Med Virol 21:128A, 1987
5. Nakano Y, Kiyosawa K, Sodeyama T, Tanaka E: Comparative study of clinical, histological and immunological responses to interferon therapy in type non-A, non-B, and type B chronic hepatitis. Am J Gastroenterol 85:24-29, 1990
6. Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y: A pilot study of Ribavirin and Interferon beta for the treatment of chronic hepatitis C. Gastroenterology 105:507-512, 1993
7. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al: Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699, 1995
8. Ruggiero V, Antonelli G, Gentile M, Conciatori G, Dianzani F: Comparative study on the antiviral activity of tumor necrosis factor (TNF)-alpha, lymphotoxin/TNF-beta and Il-1 in WISH cells. Immunol Lett 21:165-169, 1989
9. Villa E, Ferretti I, Fratti N, Trande P, De Palma M, Vecchi C, Scaglioni PP, Melegari M, Manenti F: HCV RNA in serum of asymptomatic blood donors involved in post-transfusion hepatitis (PTH). J Hepatol 13:256-259, 1991
10. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
11. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y: Typing of hepatitis C virus by polymerase chain reaction with type specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679, 1992
12. Edy VG, Billiau A, De Somer P: Non appearance of injected fibroblast interferon in circulation. Lancet 1:451-452, 1978
13. Billiau A, Heremans H, Ververken D, Van Damme J, Carton H, De Somer P: Tissue distribution of human interferons after exogenous administration in rabbits, monkeys and mice. Arch Virol 68:19-25, 1981
14. Bocci V, Pessina GP, Paulesu L, Muscettola M, Valeri A: 1. Interferon beta in rabbit plasma and lymph. J Interferon Res 8:633-640, 1988
15. Lucero MA, Magdelenat H, Fridman WH, Pouillart P, Billardon C, Billiau A, Cantell K, Falcoff E: Comparison of effects of leucocyte and fibroblast interferon on immunological parameters in cancer patients. Eur J Cancer Clin Oncol 18:243-251, 1982
16. Pouillart P, Palangie T, Jouve M, Garcia-Giralt E, Fridman WH, Magdelenat H, Falcoff E, Billiau A: Administration of fibroblast interferon to patients with advanced breast cancer: Possible effects on skin metastases and on hormone receptors. Eur J Cancer Clin Oncol 18:929-935, 1982
17. Realdi G, Diodati G, Bonetti P, Scaccabarozzi S, Alberti A, Ruol A: Recombinant human interferon alfa-2a in community acquired nonA, nonB chronic active hepatitis. Preliminary results of a randomized controlled trial. J Hepatol 11(suppl 1):S68-S71, 1990
18. Saracco G, Rosina F, Torrani-Cerenzia MR, Lattore V, Chiandussi L, Gallo V, Petrino R, DeMicheli AG, Donegani E, Solinas A: A randomized controlled trial of Interferon alfa-2b as therapy for chronic nonA, nonB hepatitis. J Hepatol 11:S43-S49, 1990
19. Chayama K, Sautoh S, Arase Y, Ikeda K, Matsumoto T, Sakai Y, Kobayashi M, Unakami M, Morinaga T, Kumada H: Effect of IFN administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. Hepatology 13:1040-1043, 1991
20. Shindo M, DiBisceglie AM, Cheung L, Shih W-K, Cristiano K, Feinstone SM, Hoofnagle JH: Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 115:700-704, 1991
21. Hagiwara H, Hayashi N, Ueda K, Takehara T, Kasahara A, Fusamoto H, Kamada T: Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon. Hepatology 15:37-41, 1992
22. Shindo M, Di Bisceglie AM, Hoofnagle JH: Long term follow-up of patients with chronic hepatitis C treated with α-interferon. Hepatology 15:1013-1016, 1992
23. Magrin S, Craxi A, Fabiano C, Fiorentino G, Marino L, Almasio P, Pinzello GB, Palazzo U, Vitale M, Maggio A: Serum hepatitis C virus (HCV)-RNA and response to alfa-interferon in anti-HCV positive chronic hepatitis. J Med Virol 38:200-206, 1992
24. Balart LA, Perrillo R, Roddenberry J, Regenstein F, Shim K-S, Shieh C, Taylor B, Dash S, Gerber MA: Hepatitis C RNA in liver of chronic hepatitis C patients before an after Interferon alfa treatment. Gastroenterology 104:1472-1477, 1993
25. Holland JJ, Spindler K, Horodyski F, Grabau E, Nichol S, Van De Pol S: Rapid evolution of RNA genomes. Science 215:1577-1585, 1982
26. Martell M, Esteban JL, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J: Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasi-species nature of HCV genome distribution. J Virol 66:3225-3229, 1992
27. Ogata N, Alter HJ, Miller RH, Purcell RH: Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Nat Acad Sci USA 88:3392-3396, 1991